| 12503464 |
1,2,5-thiadiazolidin-3-one 1,1-dioxide containing compounds and uses thereof |
Lirong Li |
2025-12-23 |
|
| RE50527 |
Covalent inhibitors of KRAS G12C |
Yi Liu, Liansheng Li, Jun Feng, Tao Wu |
2025-08-12 |
|
| 12365676 |
Heterocyclic compounds and uses thereof |
Yi Liu, Liansheng Li, Zhimin Zhu, Xiuwen Zhu |
2025-07-22 |
|
| RE50490 |
Substituted quinazoline compounds and methods of use thereof |
Liansheng Li, Jun Feng, Yun Oliver Long, Yuan Liu, Tao Wu +1 more |
2025-07-15 |
|
| 12286427 |
Heterocyclic compounds and uses thereof |
Yi Liu, Liansheng Li, Zhimin Zhu, Xiuwen Zhu |
2025-04-29 |
|
| 12234244 |
Substituted piperazines as inhibitors of KRAS G12C |
Liansheng Li, Jun Feng, Tao Wu, Yi Liu, Yuan Liu +1 more |
2025-02-25 |
|
| 12209102 |
Heterocyclic compounds and uses thereof |
Liansheng Li, Baogen Wu, Xiaoming Li, Zhiyong Chen, Siling Zhao +2 more |
2025-01-28 |
|
| 12195465 |
Macrocyclic heterocycles and uses thereof |
Baogen Wu, Zhiyong Chen, Yi Liu |
2025-01-14 |
|
| 12134620 |
Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer |
Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Yi Wang +2 more |
2024-11-05 |
|
| 12059425 |
Heterocyclic compounds and uses thereof |
Baogen Wu, Liansheng Li, Yi Liu, Siling Zhao, Xiaoming Li +2 more |
2024-08-13 |
|
| 12018011 |
Macrocyclic compounds and compositions, and methods of preparing and using the same |
Xuefeng Zhu, Zhu Bai, Wanting Xiong, Dan Xu, Yahu Arthur Liu |
2024-06-25 |
$25,231,000 |
| 11944627 |
Methods for treating hematological malignancies and Ewing's sarcoma |
Francis Burrows, Linda V. KESSLER, Liansheng Li, Yi Wang, Tao Wu +1 more |
2024-04-02 |
$27,018,000 |
| 11912708 |
Macrocyclic heterocycles and uses thereof |
Baogen Wu, Zhiyong Chen, Yi Liu |
2024-02-27 |
|
| 11878985 |
Substituted quinazolines as inhibitors of KRAS G12C |
Liansheng Li, Jun Feng, Tao Wu, Yi Liu, Yuan Liu +1 more |
2024-01-23 |
|
| RE49687 |
Thienopyrimidine and thienopyridine compounds and methods of use thereof |
Jolanta Grembecka, Tomasz Cierpicki, Dmitry Borkin, Jonathan Pollock, Hongzhi Miao +5 more |
2023-10-10 |
|
| 11673898 |
Substituted inhibitors of menin-MLL and methods of use |
Tao Wu, Liansheng Li, Yi Wang, Jolanta Grembecka, Tomasz Cierpicki +3 more |
2023-06-13 |
$4,850,000 |
| 11649251 |
Substituted inhibitors of menin-MLL and methods of use |
Tao Wu, Liansheng Li |
2023-05-16 |
$10,762,000 |
| 11648254 |
Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling |
Baogen Wu, Xiangzhu Wang, Xiaoming Li, Zhiyong Chen, Yi Liu |
2023-05-16 |
|
| 11639346 |
Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS |
Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Yi Wang +1 more |
2023-05-02 |
|
| 11555041 |
Bridged bicyclic inhibitors of menin-MLL and methods of use |
Tao Wu, Liansheng Li, Yi Wang, Jolanta Grembecka, Tomasz Cierpicki +3 more |
2023-01-17 |
$14,100,000 |
| 11547697 |
Heterocyclic compounds and uses thereof |
Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon F. Campbell |
2023-01-10 |
|
| 11542248 |
Methods and compositions for inhibiting the interaction of menin with MLL proteins |
Liansheng Li, Tao Wu, Jun Feng, Yi Liu, Jolanta Grembecka +3 more |
2023-01-03 |
$4,061,000 |
| 11542244 |
Synthesis of tipifarnib |
Xiaohu Deng, Wanping MAI |
2023-01-03 |
$4,061,000 |
| 11433065 |
Certain chemical entities, compositions and methods |
Yi Liu, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel |
2022-09-06 |
|
| 11377441 |
Covalent inhibitors of KRAS |
Liansheng Li, Jun Feng, Tao Wu, Yuan Liu, Yi Wang +1 more |
2022-07-05 |
|
